5月7日,复旦张江(01349)午前股价上涨3.13%,报2.64港元。公司公告显示,其核心药物盐酸多柔比星脂质体注射液(里葆多)于2024年首次进入国家集采目录。执行期至2027年底,因市场竞争格局变化,公司将调整销售策略及价格。自2025年5月1日起,该药物市场零售价将梯度降低,降价幅度不低于35%。2024年,该药收入约2.1亿元,占全年销售收入29%。预计此次调价将对2025年及后续...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.